Benjamin L. Digrazia, FNP

Benjamin Digrazia practices at Scripps Green Hospital in La Jolla, California, part of Scripps Health.

Benjamin Digrazia's NPI, 1528542503, was assigned on September 17, 2018. Benjamin Digrazia holds California license 95009297.

Benjamin Digrazia's primary practice is Scripps Green Hospital, at 10666 North Torrey Pines Road, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 554-3600.

Benjamin Digrazia's primary practice is Scripps Green Hospital in La Jolla, California, part of Scripps Health. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Benjamin Digrazia to 1 more breast imaging center and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Benjamin Digrazia practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Benjamin Digrazia's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Benjamin Digrazia is licensed in California.

Dmand AI lists chronic kidney disease, fluid and electrolyte imbalances and tobacco use among the conditions Benjamin Digrazia treats.

CMS data shows 313 Medicare services from Benjamin Digrazia across 3 procedure codes in 2024, for 229 Medicare patients. Medicare paid $27,406 for them. Every service was in an office.

CMS counts 229 Medicare patients who saw Benjamin Digrazia in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Benjamin Digrazia's median patient age at 76, with 54% women.

In 2024, Benjamin Digrazia wrote 2,570 Medicare Part D claims for 512 patients. 89% of them were for generic drugs. CMS names the drug for 2,213 of them, across 54 drugs with 11 or more claims each, at $252,491 in total drug cost.

Benjamin Digrazia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Benjamin Digrazia as offering telehealth.

CMS Open Payments shows 3 general payments to Benjamin Digrazia from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $73.